A combination of recombinant BCG expressing pneumococcal proteins induces cellular and humoral immune responses and protects against pneumococcal colonization and sepsis
Clinical and Vaccine Immunology
August 03, 2017
Goulart C, et al.
In order to find out if a combination of recombinant BCG expressing pneumococcal proteins induces cellular and humoral immune responses and protects against pneumococcal colonization and sepsis, experts conduct this study. The use of combined rBCG strains as a potentially serotype– transcending pneumococcal vaccine in a prime–boost strategy, has been proposed. It appears to provide protection against pneumococcal colonization and sepsis.
Your browser is currently blocking ads. We depend on ad sponsorships in order to keep this site free to the healthcare provider community. Help us keep this site free by turning off your ad blocker.
Turn Off Ad Blocker
We have detected that you are currently blocking ads. We kindly ask that you enable ads when visiting our site. We depend on ad sponsorships in order to keep this site free to the healthcare provider community.